Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection.

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)130-141
JournalClinical Immunology
Volume140
Issue number2
DOIs
Publication statusPublished - 2011

Cite this

@article{523b9414925d4c6e84ac74620419daf6,
title = "Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection.",
author = "F.L. Schneiders and R.J. Scheper and {von Blomberg}, B.M.E. and A.M. Woltman and H.L.A. Janssen and {van den Eertwegh}, A.J.M. and H.M.W. Verheul and {de Gruijl}, T.D. and {van der Vliet}, J.J.",
year = "2011",
doi = "10.1016/j.clim.2010.11.010",
language = "English",
volume = "140",
pages = "130--141",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "2",

}

Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection. / Schneiders, F.L.; Scheper, R.J.; von Blomberg, B.M.E.; Woltman, A.M.; Janssen, H.L.A.; van den Eertwegh, A.J.M.; Verheul, H.M.W.; de Gruijl, T.D.; van der Vliet, J.J.

In: Clinical Immunology, Vol. 140, No. 2, 2011, p. 130-141.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection.

AU - Schneiders, F.L.

AU - Scheper, R.J.

AU - von Blomberg, B.M.E.

AU - Woltman, A.M.

AU - Janssen, H.L.A.

AU - van den Eertwegh, A.J.M.

AU - Verheul, H.M.W.

AU - de Gruijl, T.D.

AU - van der Vliet, J.J.

PY - 2011

Y1 - 2011

U2 - 10.1016/j.clim.2010.11.010

DO - 10.1016/j.clim.2010.11.010

M3 - Article

VL - 140

SP - 130

EP - 141

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 2

ER -